Cart
sales@molnova.com
RKI-1313
CAS No. 1342276-76-9
RKI-1313( RKI-1313 | RKI 1313 | RKI1313 )
Catalog No. M11371 CAS No. 1342276-76-9
RKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 155 | In Stock |
|
| 5MG | 138 | In Stock |
|
| 10MG | 207 | In Stock |
|
| 25MG | 369 | In Stock |
|
| 50MG | 528 | In Stock |
|
| 100MG | 755 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRKI-1313
-
NoteResearch use only, not for human use.
-
Brief DescriptionRKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.
-
DescriptionRKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.
-
In Vitro——
-
In Vivo——
-
SynonymsRKI-1313 | RKI 1313 | RKI1313
-
PathwayCell Cycle/DNA Damage
-
TargetROCK
-
RecptorROCK1| ROCK2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1342276-76-9
-
Formula Weight340.4
-
Molecular FormulaC17H16N4O2S
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESO=C(NC1=NC(C2=CC=NC=C2)=CS1)NCC3=CC=CC(OC)=C3
-
Chemical Name1-(3-Methoxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Patel RA, et al. Y Res. 2012 Oct 1;72(19): 5025-34.
molnova catalog
related products
-
Netarsudil mesylate
Netarsudil mesylate (AR-13324 mesylate) is a Rho-related protein kinase inhibitor used to study glaucoma and hypertension.
-
Y-27632 dihydrochlor...
Y-27632 2hydrochloride is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM in a cell-free assay.
-
ROCK-IN-5
ROCK-IN-5 (compound I-B-37) is a potent inhibitor of protein kinases, including ROCK, ERK, GSK, and AGC, with potential applications in cardiac, proliferative, and neurodegenerative disease research.
